Pancreatic cancer discovery opens the door fo

<p>A new scientific finding at the University of Rochester is the foundation for&nbsp;the first clinical trial in the U.S. to study an experimental drug&#39;s ability to fight pancreatic cancer with metastasis&nbsp;to the liver. The trial is expected to launch early in 2024 at UR&#39;s Wilmot Cancer Institute.&nbsp;</p>

<p>&nbsp;</p>

<p>&nbsp;</p>

Related Keywords

Fox Chase Cancer Center ,Pennsylvania ,United States ,France ,Philadelphia ,Scott Gerber ,Darren Carpizo ,David Linehan ,Nabeel Badri ,Netris Pharma ,Aram Hezel ,Rutgers University ,Method Of Research ,University Of Rochester Wilmot Cancer Institute ,University Of Rochester Medical Center ,Pancreatic Cancer Action Network Pan ,Wilmot Cancer Institute ,Surgical Oncology ,Rochester Medical ,Cell Reports ,Pancreatic Cancer Action Network ,Chair David Linehan ,Cancer Microenvironment ,